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Recently, two large genome-wide association studies, conducted in Chinese populations, have reported associations between upper gastrointestinal cancer and the rs2274223, rs13042395 and rs4072037 polymorphisms in PLCE1, C20orf54 and MUC1, respectively. We aimed to determine whether similar associations existed for Caucasian populations. We genotyped two population-based, case-control studies of upper gastrointestinal cancer; the first study included 290 gastric cancer (GC) cases and 376 controls and the second study included 306 GC cases, 107 oesophageal adenocarcinoma cancer cases, 52 oesphageal squamous cell cancer cases and 211 controls. Odds ratios (OR) and 95% confidence intervals (CIs) were computed from logistic models and adjusted for confounding variables. The rs4072037 polymorphism in MUC1 was associated with a reduced risk of GC of intestinal histological type (OR 0.4; 95% CI 0.2-0.9) and a reduced risk of oesophageal squamous cell cancer (OR 0.5; 95% CI 0.2-1.0), but not oesphageal adenocarcinoma. Similarly, rs2274223 in PLCE1 was associated with a reduced risk of oesophageal squamous cell cancer (OR 0.5; 95% CI 0.3-1.0), but not oesphageal adenocarcinoma. We observed no association between rs13042395 in Corf54 and the risk of gastric or oesphageal cancer in either of the two studies. Our findings for rs4072037 and the risk of GC are in agreement with one previous report for a Caucasian population. To the best of our knowledge, this is the first study to report an association between rs2274223 and rs4072037 and the risk of oesophageal squamous cell carcinoma in a Caucasian population. European Journal of Cancer 
Introduction
There have been considerable advances in our understanding of the genetic basis of gastric and oesphageal cancers [upper gastrointestinal (GI) cancers]. This has been the result of well-powered, genome-wide association studies (GWAS) exploring the relationship between a large number of single nucleotide polymorphisms (SNPs) and disease predisposition. Recently, two large GWAS, conducted in Chinese populations, reported associations between gastric cancer (GC) and oesphageal squamous cell carcinoma (OSCC), and a number of previously unknown diseasesusceptibility loci at 1q22, 10q23 and 20p13 (Abnet et al., 2010; Wang et al., 2010) . Of particular interest were three SNPs: rs2274223 (G > A) in PLCE1 at 10q23 and rs13042395 (T > C) in C20orf54 at 20p13, which were shown to increase the risk for GC and OSCC, and rs4072037 (G > A) in MUC1 at 1q22, which was shown to confer protection against GC. We aimed to determine whether similar associations existed for Caucasian populations.
Materials and methods

Study groups
We genotyped two, Caucasian, population-based, case-control studies of upper GI cancer: the first study included 290 GC cases (predominantly noncardia GC) and 376 controls derived from a population in Warsaw, Poland (Chow et al., 1999) , and the second study, derived from three distinct geographical areas of the USA with population-based cancer registries, included 122 cardia GC cases, 184 noncardia GC cases, 107 oesophageal adenocarcinoma cancer cases (OACC), 52 OSCC, and 211 controls (Gammon et al., 1997) .
Genotyping DNA samples were genotyped by real-time PCR allelic discrimination using the ABI 7900HT Fast Sequence Detection System (Applied Biosystems, Foster City, California, USA). Predesigned TaqMan SNP genotyping assays were used, with minor groove binding probes 5 0 -labelled with VIC or FAM fluorophores to detect the allelic variants in rs2274223, rs13042395 and rs4072037 (Applied Biosystems). Following analysis of real-time data, genotyping calls were possible in 98% of samples for the rs13042395 and rs4072037 SNPs and greater than 96% for the rs2274223 SNP.
Statistics
Hardy-Weinberg equilibrium of alleles was assessed at the polymorphic loci by w 2 statistics. Odds ratios (OR) with Cornfield 95% confidence intervals (CIs) were computed by logistic regression and adjusted for age and sex using STATA software (version 7.0; STATA Press, College Station, Texas, USA).
Results
For all three SNP, the distribution of alleles was in Hardy-Weinberg equilibrium, with nonsignificant w 2 values in both control groups.
The rs4072037 polymorphism (G > A) in MUC1 was inversely associated with the risk of intestinal GC, and OSCC, in the US study group (Table 1) . For intestinaltype GC, the association was observed for heterozygotes (OR 0.4; 95% CI 0.2-0.9), and in a dominant model (OR 0.4; 95% CI 0.2-0.9). Similarly, for OSCC, the association was observed for heterozygotes (OR 0.4; 95% CI 0.2-0.9) and in the dominant model (OR 0.5; 95% CI 0.2-1.0).
The rs2274223 polymorphism (G > A) in PLCE1 was inversely associated with the risk of OSCC in the US study group. The association was significant in heterozygotes (OR 0.5; 95% CI 0.2-1.0) and in a dominant model (OR 0.5; 95% CI 0.3-1.0) (see Table 2 ). No associations were observed between the rs2274223 polymorphism and GC in either the Polish or the US study group.
No associations were observed between the rs13042395 polymorphism in C20orf54 and the risk of upper GI cancer in either study population (results not shown).
Discussion
The rs2274223 polymorphism in PLCE1 was identified as a risk factor for GC and OSCC in Han Chinese populations by two contemporary independent GWAS (Abnet et al., 2010; Wang et al., 2010) .
The association with GC was subsequently reproduced in another study in Han Chinese . In Caucasian populations, associations have been reported between rs2274223 and the risk for nonoropharyngeal squamous cell carcinoma of the head and neck (Ma et al., 2011) . Our finding of an association with OSCC is in contrast to those reported in the literature; such effects themselves are not, however, novel, with contrasting effects observed for other SNPs reported for different tumour sites (Lochhead et al., 2011) . Interestingly, the results of a study in a Chinese population suggest that rs2274223 confers a survival advantage in GC (Luo et al., 2011) .
PLCE1 encodes an enzyme that catalyses the hydrolysis of phosphatidylinositol-4,5-bisphosphate, generating the secondary messengers inositol 1,4,5-trisphosphate and diacylglycerol, which participate in cell growth, differentiation and gene expression (Bunney et al., 2009) . PLCE1 is regulated by small GTPases of the Ras, Rap and Rho families, and contains a guanine nucleotide exchange factor domain for Ras-like small GTPases at its N-terminus and two Ras-binding domains at its C-terminus (Kelley et al., 2001; Wing et al., 2003; Bunney et al., 2009) . The latter two domains bind directly to H-ras (Kelley et al., 2001) . PLCE1 also interacts with IQ-domain GTPase-activating protein 1 (IQGAP1) (Hinkes et al., 2006) . IQGAP1 plays important roles in angiogenesis and is expressed in endothelial cells, where it binds VEGFR2, an important factor for endothelial cell rearrangement and migration (Johnson et al., 2009 ).
With little knowledge of rs2274223 before the aforementioned GWAS, no functional data exist. In colorectal cancer, PLCE1 expression is significantly downregulated compared with the normal colonic mucosa, with increasing suppression of PLCE1 correlated with advancing tumour stage (Danielsen et al., 2011) . In a colorectal cancer cell line, overexpression of PLCE1 was found to inhibit cell proliferation and promote apoptosis . These findings suggest that PLCE1 functions as a tumour suppressor gene; however, tumourpromoting effects have also been reported for PLCE1. In the ApcMin/ + mouse, knockout of PLCE1 was associated with resistance to tumour development through attenuation of angiogenesis and tumour-associated inflammation (Li et al., 2009) . Similar proinflammatory actions have been observed in skin carcinogenesis (Bai et al., 2004) .
The finding that rs4072037 in MUC1 protects against GC has been validated in Han Chinese (Shi et al., 2011; Zhang et al., 2011) , Japanese, South Korean (Saeki et al., 2011) and Caucasian populations (Jia et al., 2010) .
The mucin MUC1 is a highly glycosylated transmembrane glycoprotein that is a major component of the viscous mucous layer protecting epithelial surfaces. Functional studies have shown that rs4072037, in the MUC1 gene, regulates alternative splicing of the second exon and modifies the transcriptional activity of the promoter (Saeki et al., 2011) . However, the mechanism by which rs4072037 contributes to GC development is yet to be elucidated.
More recently, it has been shown that MUC1 participates intracellularly in the activation of the NF-kB, leading to upregulation of cytokines IL-6 and TNF-a (Cascio et al., 2011) . This is an interesting and novel observation, given that the prognosis in both GC and OSCC is inversely associated with MUC1 expression (Utsunomiya et al., 1998; Ye et al., 2011) . Moreover, MUC1 expression in OSCC upregulates the expression of matrix metalloproteinase 13, a protein that is highly expressed in tumours of patients with metastatic OSCC, and that is indirectly regulated by NF-kB through the production of proinflammatory cytokines (Ye et al., 2011) . As such, this provides a potential mechanism by which tumours can promote inflammation and tumour development through MUC1 expression.
Although it is a risk factor for upper GI cancer in Asians, our data do not support a role for rs13042395 and the risk of upper GI cancer in Caucasians. However, as the minor allele occurred at such a low frequency in our study populations, we cannot exclude the possibility that we were unable to detect an association because of lack of power.
The rs2274223 SNP has been reported by others to be in linkage disequilibrium with NOC3L and another SNP in PLCE1, rs3203713 . In addition, rs4072037 has been reported to be in linkage disequilibrium with the small allele of the variable number of tandem repeats in the second intron of MUC1 (Jia et al., 2010) . With no functional data, it is possible that the associations we observed are because of linkage with these or another functional polymorphism in the same region.
The fact that our observed associations were most apparent in heterozygotes is worth some consideration. Although this could be because of a heterozygote advantage, it is likely that these findings reflect power limitations due to a small number of homozygote minor allele cases in the study groups. Indeed, in support of this explanation, our dominant models are in accordance with the observed associations for heterozygotes. Oesphageal cancer Adenocarcinoma 44/86 1.0 (reference) 50/107 0.9 (0.5-1.5); 0.719 13/17 1.5 (0.6-3.6); 0.328 1.0 (0.6-1.6); 0.977 1.6 (0.7-3.6); 0.244 Squamous cell 30/86 1.0 (reference) Given that we considered this an exploratory study, we have not corrected for multiple comparisons and cannot exclude the possibility that the significant findings have arisen by chance. Furthermore, the small number of OSCC cases in the US study results in large CIs for these ORs. However, we believe that the novelty and potential importance of our findings merit their validation in additional Caucasian studies of upper GI malignancy.
In conclusion, this study has added to our knowledge of the complex genetic interactions that define the risk of upper GI cancer in Caucasians. These findings may provide an insight into the molecular pathogenesis of upper GI malignancy and, in the future, may contribute to individual risk stratification for prevention and screening.
